SUPERNUS PHARMACEUTICALS INC

Profile

Company Names

SUPERNUS PHARMACEUTICALS INC

Addresses

1550 E GUDE DR, ROCKVILLE, MD 20850

Phone Numbers

301-838-2500

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$30,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2011-01-26 
$30,000,000.00 
$30,000,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAOLO 
 
BAROLDI, M.D., PH.D. 
EXECUTIVE OFFICER
SUPERNUS PHARMACEUTICALS INC
M. 
JAMES 
BARRETT, PH.D. 
DIRECTOR
SENSORS FOR MEDICINE + SCIENCE INC   |  ZOSANO PHARMA INC   |  SUPERNUS PHARMACEUTICALS INC
PADMANABH 
P. 
BHATT, PH.D. 
EXECUTIVE OFFICER
SUPERNUS PHARMACEUTICALS INC
MICHAEL 
 
BIGHAM 
DIRECTOR
PRIMERA BIOSYSTEMS INC   |  SUPERNUS PHARMACEUTICALS INC   |  VALERITAS INC   |  PARATEK PHARMACEUTICALS INC   |  AVEDRO INC   |  ABINGWORTH BIOVENTURES VII LP
JONES 
W. 
BRYAN, PH.D. 
EXECUTIVE OFFICER
SUPERNUS PHARMACEUTICALS INC
FREDERICK 
M. 
HUDSON 
DIRECTOR
VICOR TECHNOLOGIES, INC.   |  SUPERNUS PHARMACEUTICALS INC
JACK 
A. 
KHATTAR 
EXECUTIVE OFFICER, DIRECTOR
SUPERNUS PHARMACEUTICALS INC
TAMI 
T. 
MARTIN, R.N., ESQ. 
EXECUTIVE OFFICER
SUPERNUS PHARMACEUTICALS INC
CHARLES 
W. 
NEWHALL, III 
DIRECTOR
SUPERNUS PHARMACEUTICALS INC
WILLIAM 
A. 
NUERGE 
DIRECTOR
SUPERNUS PHARMACEUTICALS INC
MICHAEL 
B. 
SHEFFERY, PH.D. 
DIRECTOR
SUPERNUS PHARMACEUTICALS INC
JOHN 
M. 
SIEBERT 
DIRECTOR
SUPERNUS PHARMACEUTICALS INC   |  CHASE PHARMACEUTICALS CORP   |  ACCU-BREAK PHARMACEUTICALS, INC.   |  ARADIGM CORP
RUSSELL 
P. 
WILSON 
EXECUTIVE OFFICER
SUPERNUS PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-02-16
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2011-01-26 
2011-02-02
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2011-01-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#